PT1132393E
(pt)
*
|
1996-10-16 |
2003-08-29 |
Ribapharm Inc |
L-ribavirina e usos da mesma
|
YU67099A
(sh)
*
|
1997-06-30 |
2002-06-19 |
Icn Pharmaceuticals Inc. |
Postupak za dobijanje tiazofurina i drugih c-nukleozida
|
JP4596495B2
(ja)
*
|
1997-07-18 |
2010-12-08 |
ソニー株式会社 |
制御装置、制御方法、電気機器システム、電気機器システムの制御方法、および、記録媒体
|
US7901400B2
(en)
|
1998-10-23 |
2011-03-08 |
Covidien Ag |
Method and system for controlling output of RF medical generator
|
MXPA01004504A
(es)
|
1998-11-05 |
2005-04-19 |
Centre Nat Rech Scient |
Nucleosidos con actividad contra virus de la hepatitis b.
|
US6407077B1
(en)
|
1998-11-05 |
2002-06-18 |
Emory University |
β-L nucleosides for the treatment of HIV infection
|
JP2002528510A
(ja)
*
|
1998-11-05 |
2002-09-03 |
サントル・ナシオナル・ドウ・ラ・ルシエルシユ・シアンテイフイク |
HIV感染の治療のためのβ−L−2’−デオキシ−ヌクレオシド
|
BR9917090A
(pt)
*
|
1999-01-29 |
2001-10-16 |
Icn Pharmaceuticals |
Modulação de resposta imune por ribavirina
|
US7084125B2
(en)
|
1999-03-18 |
2006-08-01 |
Exiqon A/S |
Xylo-LNA analogues
|
KR100782896B1
(ko)
|
1999-05-04 |
2007-12-06 |
엑시콘 에이/에스 |
L-리보-lna 유사체
|
US6525191B1
(en)
*
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
CA2382324A1
(en)
*
|
1999-08-31 |
2001-03-08 |
Amersham Plc |
Nucleoside analogues
|
US6664399B1
(en)
*
|
1999-09-02 |
2003-12-16 |
E. I. Du Pont De Nemours & Company |
Triazole linked carbohydrates
|
US6518253B1
(en)
*
|
1999-11-19 |
2003-02-11 |
Robert Tam |
Treatment of viral infections using the L-isomer of ribavirin
|
YU47802A
(sh)
*
|
1999-12-23 |
2006-03-03 |
Ribapharm |
Postupci i kompozicije za levovirin
|
US7638496B2
(en)
|
2000-02-15 |
2009-12-29 |
Valeant Pharmaceuticals North America |
Nucleoside analogs with carboxamidine modified monocyclic base
|
US6455508B1
(en)
*
|
2000-02-15 |
2002-09-24 |
Kanda S. Ramasamy |
Methods for treating diseases with tirazole and pyrrolo-pyrimidine ribofuranosyl nucleosides
|
US6495677B1
(en)
|
2000-02-15 |
2002-12-17 |
Kanda S. Ramasamy |
Nucleoside compounds
|
BR0110023A
(pt)
*
|
2000-04-13 |
2003-12-30 |
Pharmasset Ltd |
Derivados de nucleosìdeo 3'-ou-2' substituìdos para tratamento de infecções por vìrus da hepatite
|
MY164523A
(en)
*
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
EP1294735A2
(de)
*
|
2000-05-26 |
2003-03-26 |
Novirio Pharmaceuticals Limited |
Verfahren und zusammensetzungen zur behandlung von flaviviren und pestiviren
|
US6815542B2
(en)
*
|
2000-06-16 |
2004-11-09 |
Ribapharm, Inc. |
Nucleoside compounds and uses thereof
|
US6680059B2
(en)
|
2000-08-29 |
2004-01-20 |
Tripep Ab |
Vaccines containing ribavirin and methods of use thereof
|
US7022830B2
(en)
*
|
2000-08-17 |
2006-04-04 |
Tripep Ab |
Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
|
RU2286172C2
(ru)
|
2000-08-17 |
2006-10-27 |
Трипеп Аб |
Вакцины, содержащие рибавирин, и способы их использования
|
EP2332574A1
(de)
|
2000-08-17 |
2011-06-15 |
Tripep Ab |
HCV NS3/4A Sequenzen
|
US6720000B2
(en)
*
|
2001-03-19 |
2004-04-13 |
Three Rivers Pharmaceutical, Llc |
Process for producing wet ribavirin pellets
|
ES2208540T3
(es)
*
|
2001-07-30 |
2004-06-16 |
Clariant Life Science Molecules (Italia) Spa |
Procedimiento para la preparacion de ribavirina.
|
EP1435974A4
(de)
*
|
2001-09-28 |
2006-09-06 |
Idenix Cayman Ltd |
Verfahren und zusamemnsetzungen zur behandlung des hepatitis-c-virus mit 4'-modifizierten nucleosiden
|
WO2003039517A1
(en)
*
|
2001-11-02 |
2003-05-15 |
Sandoz Inc. |
Process for preparing quick dissolving, high loading ribavirin compositions
|
KR100411398B1
(ko)
*
|
2001-12-06 |
2003-12-18 |
주식회사유한양행 |
베타-디-리보푸라노즈 유도체의 제조방법
|
AU2003213628A1
(en)
*
|
2002-02-28 |
2003-09-16 |
Biota, Inc. |
Nucleoside 5'-monophosphate mimics and their prodrugs
|
EP1501435B1
(de)
|
2002-05-06 |
2007-08-29 |
Covidien AG |
Blutdetektor zur kontrolle einer elektrochirurgischen einheit
|
US6982253B2
(en)
|
2002-06-05 |
2006-01-03 |
Supergen, Inc. |
Liquid formulation of decitabine and use of the same
|
US7608600B2
(en)
*
|
2002-06-28 |
2009-10-27 |
Idenix Pharmaceuticals, Inc. |
Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
|
KR20050035194A
(ko)
*
|
2002-06-28 |
2005-04-15 |
이데닉스 (케이만) 리미티드 |
플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
|
CN101172993A
(zh)
*
|
2002-06-28 |
2008-05-07 |
埃迪尼克斯(开曼)有限公司 |
用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷
|
JP2006507235A
(ja)
*
|
2002-08-01 |
2006-03-02 |
フアーマセツト・インコーポレイテツド |
フラビウイルス科ウイルス感染治療のためのビシクロ[4.2.1]ノナン系を有する化合物
|
EP1537134B1
(de)
*
|
2002-08-12 |
2006-04-05 |
F.Hoffmann-La Roche Ag |
Verfahren zur herstellung von einem ribofuranose
|
US7538094B2
(en)
*
|
2002-09-19 |
2009-05-26 |
Three Rivers Pharmacueticals, Llc |
Composition containing ribavirin and use thereof
|
US20040077607A1
(en)
*
|
2002-10-21 |
2004-04-22 |
Uckun Fatih M. |
Aryl phosphate derivatives of d4T with potent anti-viral activity against hemorrhagic fever viruses
|
ZA200503511B
(en)
|
2002-10-29 |
2006-10-25 |
Coley Pharmaceutical Group Ltd |
Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
|
CN1849142A
(zh)
*
|
2002-11-15 |
2006-10-18 |
埃迪尼克斯(开曼)有限公司 |
2′-支链核苷和黄病毒突变
|
US7044948B2
(en)
|
2002-12-10 |
2006-05-16 |
Sherwood Services Ag |
Circuit for controlling arc energy from an electrosurgical generator
|
US7598373B2
(en)
*
|
2002-12-12 |
2009-10-06 |
Idenix Pharmaceuticals, Inc. |
Process for the production of 2-C-methyl-D-ribonolactone
|
AU2003300434A1
(en)
*
|
2002-12-23 |
2004-07-22 |
Idenix (Cayman) Limited |
Process for the production of 3'-nucleoside prodrugs
|
US7038038B2
(en)
*
|
2003-03-17 |
2006-05-02 |
Pharmion Corporation |
Synthesis of 5-azacytidine
|
US6887855B2
(en)
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
US6943249B2
(en)
|
2003-03-17 |
2005-09-13 |
Ash Stevens, Inc. |
Methods for isolating crystalline Form I of 5-azacytidine
|
CA2529311A1
(en)
*
|
2003-03-28 |
2004-10-07 |
Pharmasset, Inc. |
Compounds for the treatment of flaviviridae infections
|
WO2004098385A2
(en)
|
2003-05-01 |
2004-11-18 |
Sherwood Services Ag |
Method and system for programing and controlling an electrosurgical generator system
|
EP2345661A1
(de)
|
2003-05-30 |
2011-07-20 |
Pharmasset, Inc. |
Modifizierte fluorinierte Nukleosidanaloga
|
US6930093B2
(en)
*
|
2003-07-10 |
2005-08-16 |
Valeant Research & Development |
Use of ribofuranose derivatives against inflammatory bowel diseases
|
US20050009848A1
(en)
*
|
2003-07-10 |
2005-01-13 |
Icn Pharmaceuticals Switzerland Ltd. |
Use of antivirals against inflammatory bowel diseases
|
DK1658302T3
(da)
|
2003-07-25 |
2010-11-22 |
Idenix Pharmaceuticals Inc |
Purinnukleosidanaloge til behandling af sygdomme forårsaget af Flavirividae, herunder hepatitis C
|
WO2005018330A1
(en)
*
|
2003-08-18 |
2005-03-03 |
Pharmasset, Inc. |
Dosing regimen for flaviviridae therapy
|
CA2542798C
(en)
|
2003-10-23 |
2015-06-23 |
Sherwood Services Ag |
Thermocouple measurement circuit
|
EP1675499B1
(de)
|
2003-10-23 |
2011-10-19 |
Covidien AG |
Redundante temperaturüberwachung für elektrochirurgische systeme zur sicherheitserhöhung
|
US7396336B2
(en)
|
2003-10-30 |
2008-07-08 |
Sherwood Services Ag |
Switched resonant ultrasonic power amplifier system
|
US7131860B2
(en)
|
2003-11-20 |
2006-11-07 |
Sherwood Services Ag |
Connector systems for electrosurgical generator
|
US7766905B2
(en)
|
2004-02-12 |
2010-08-03 |
Covidien Ag |
Method and system for continuity testing of medical electrodes
|
US20050182252A1
(en)
|
2004-02-13 |
2005-08-18 |
Reddy K. R. |
Novel 2'-C-methyl nucleoside derivatives
|
US7780662B2
(en)
|
2004-03-02 |
2010-08-24 |
Covidien Ag |
Vessel sealing system using capacitive RF dielectric heating
|
EP1912643A2
(de)
*
|
2004-06-23 |
2008-04-23 |
Idenix (Cayman) Limited |
5-aza-7-deazapurinderivate zur behandlung von infektionen mit flaviviridae
|
CN101023094B
(zh)
*
|
2004-07-21 |
2011-05-18 |
法莫赛特股份有限公司 |
烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备
|
AU2005285045B2
(en)
|
2004-09-14 |
2011-10-13 |
Gilead Pharmasset Llc |
Preparation of 2'fluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
|
WO2006074416A1
(en)
*
|
2005-01-07 |
2006-07-13 |
Health Research Inc. |
5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
|
US7250416B2
(en)
|
2005-03-11 |
2007-07-31 |
Supergen, Inc. |
Azacytosine analogs and derivatives
|
JP4516863B2
(ja)
*
|
2005-03-11 |
2010-08-04 |
株式会社ケンウッド |
音声合成装置、音声合成方法及びプログラム
|
WO2006105440A2
(en)
*
|
2005-03-30 |
2006-10-05 |
Sirtris Pharmaceuticals, Inc. |
Nicotinamide riboside and analogues thereof
|
US20070014833A1
(en)
*
|
2005-03-30 |
2007-01-18 |
Sirtris Pharmaceuticals, Inc. |
Treatment of eye disorders with sirtuin modulators
|
CA2618429A1
(en)
*
|
2005-05-25 |
2007-03-22 |
Tripep Ab |
A hepatitis c virus non-structural ns3/4a fusion gene
|
US20060292099A1
(en)
*
|
2005-05-25 |
2006-12-28 |
Michael Milburn |
Treatment of eye disorders with sirtuin modulators
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
US8734438B2
(en)
|
2005-10-21 |
2014-05-27 |
Covidien Ag |
Circuit and method for reducing stored energy in an electrosurgical generator
|
US7947039B2
(en)
|
2005-12-12 |
2011-05-24 |
Covidien Ag |
Laparoscopic apparatus for performing electrosurgical procedures
|
EP1976382B1
(de)
*
|
2005-12-23 |
2013-04-24 |
IDENIX Pharmaceuticals, Inc. |
Verfahren zur herstellung eines synthetischen zwischenprodukts für die herstellung von verzweigten nukleosiden
|
US7651493B2
(en)
|
2006-03-03 |
2010-01-26 |
Covidien Ag |
System and method for controlling electrosurgical snares
|
CN101511379A
(zh)
*
|
2006-03-09 |
2009-08-19 |
Om药物公司 |
免疫调节化合物和治疗与炎性细胞因子过度产生相关的疾病的方法
|
FR2907786B1
(fr)
*
|
2006-10-27 |
2009-09-18 |
Univ Grenoble 1 |
Thionucleosides et applications pharmaceutiques
|
CN101511185A
(zh)
*
|
2006-09-11 |
2009-08-19 |
南方研究所 |
唑类核苷和作为rna和dna病毒聚合酶抑制剂的用途
|
EP2105445A4
(de)
*
|
2006-12-08 |
2014-01-22 |
Api Corp |
Verfahren zur herstellung eines furanosederivats
|
WO2008086341A1
(en)
*
|
2007-01-09 |
2008-07-17 |
Pericor Therapeutics, Inc. |
Methods. compositions, and formulations for preventing or reducing adverse effects in a patient
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
EP2185195A2
(de)
*
|
2007-08-16 |
2010-05-19 |
Tripep Ab |
Immunogen-plattform
|
EP2200611A4
(de)
|
2007-09-14 |
2010-09-22 |
Biogen Idec Inc |
Zusammensetzungen und verfahren zur behandlung von progressiver multifokaler leukoenzephalopathie (pml)
|
US8227431B2
(en)
|
2008-03-17 |
2012-07-24 |
Hetero Drugs Limited |
Nucleoside derivatives
|
WO2009130588A2
(en)
*
|
2008-04-22 |
2009-10-29 |
Tripep Ab |
Immunogen platform
|
AU2009246926B2
(en)
|
2008-05-15 |
2014-06-26 |
Celgene Corporation |
Oral formulations of cytidine analogs and methods of use thereof
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
AU2009329872B2
(en)
|
2008-12-23 |
2016-07-07 |
Gilead Pharmasset Llc |
Synthesis of purine nucleosides
|
SG172361A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside analogs
|
EP2408306A4
(de)
*
|
2009-03-20 |
2012-11-07 |
Alios Biopharma Inc |
Substituierte nukleosid- und nukleotid-analoga
|
TWI583692B
(zh)
|
2009-05-20 |
2017-05-21 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
EP2752422B1
(de)
|
2010-03-31 |
2017-08-16 |
Gilead Pharmasset LLC |
Stereoselektive synthese von phosphorhaltigen wirkstoffen
|
US8563530B2
(en)
|
2010-03-31 |
2013-10-22 |
Gilead Pharmassel LLC |
Purine nucleoside phosphoramidate
|
WO2012040124A1
(en)
|
2010-09-22 |
2012-03-29 |
Alios Biopharma, Inc. |
Azido nucleosides and nucleotide analogs
|
NZ607996A
(en)
|
2010-09-22 |
2014-07-25 |
Alios Biopharma Inc |
Substituted nucleotide analogs
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
GB201021867D0
(en)
*
|
2010-12-23 |
2011-02-02 |
Mologen Ag |
Non-coding immunomodulatory DNA construct
|
CN102153548B
(zh)
*
|
2011-02-24 |
2012-11-28 |
河北大学 |
一种含有噻唑(嗪)烷酮环的类核苷衍生物及其制备方法和其在药物制剂中的应用
|
US9951098B2
(en)
|
2011-03-31 |
2018-04-24 |
Pharmion Llc |
Synthesis of 5-azacytidine
|
AU2012302051B2
(en)
|
2011-08-30 |
2017-04-27 |
Astex Pharmaceuticals, Inc. |
Decitabine derivative formulations
|
MD4589C1
(ro)
|
2011-09-16 |
2019-03-31 |
Gilead Pharmasset Llc |
Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
EP2794630A4
(de)
|
2011-12-22 |
2015-04-01 |
Alios Biopharma Inc |
Substituierte phosphorthioat-nukleotidanaloga
|
UY34536A
(es)
|
2011-12-22 |
2013-07-31 |
Alios Biopharma Inc |
Nucleósidos sustituidos, nucleótidos y análogos de los mismos
|
USRE48171E1
(en)
|
2012-03-21 |
2020-08-25 |
Janssen Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
US9441007B2
(en)
|
2012-03-21 |
2016-09-13 |
Alios Biopharma, Inc. |
Substituted nucleosides, nucleotides and analogs thereof
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
WO2013142157A1
(en)
|
2012-03-22 |
2013-09-26 |
Alios Biopharma, Inc. |
Pharmaceutical combinations comprising a thionucleotide analog
|
UY34824A
(es)
|
2012-05-25 |
2013-11-29 |
Janssen R & D Ireland |
Nucleósidos de espirooxetano de uracilo
|
KR102168621B1
(ko)
|
2012-12-21 |
2020-10-22 |
얀센 바이오파마, 인코퍼레이트. |
치환된 뉴클레오사이드, 뉴클레오타이드 및 그것의 유사체
|
NZ625087A
(en)
|
2013-01-31 |
2017-05-26 |
Gilead Pharmasset Llc |
Combination formulation of two antiviral compounds
|
US20140309164A1
(en)
|
2013-04-12 |
2014-10-16 |
Achillion Pharmaceuticals, Inc. |
Deuterated nucleoside prodrugs useful for treating hcv
|
ES2900570T3
(es)
|
2013-08-27 |
2022-03-17 |
Gilead Pharmasset Llc |
Formulación de combinación de dos compuestos antivirales
|
SG11201602595TA
(en)
|
2013-10-11 |
2016-04-28 |
Alios Biopharma Inc |
Substituted nucleosides, nucleotides and analogs thereof
|
EP3092001B1
(de)
|
2014-01-07 |
2020-10-07 |
Babita Agrawal |
Immunmodulierende zusammensetzungen und verfahren zur verwendung davon
|
US10449210B2
(en)
|
2014-02-13 |
2019-10-22 |
Ligand Pharmaceuticals Inc. |
Prodrug compounds and their uses
|
RU2016149767A
(ru)
|
2014-06-06 |
2018-07-16 |
Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед |
Аналоги никотинамидрибозида и фармацевтические композиции и их применение
|
JP2017520545A
(ja)
|
2014-07-02 |
2017-07-27 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
US10273305B2
(en)
|
2015-04-02 |
2019-04-30 |
Ablynx N.V. |
Bispecific CXCR4-CD4 polypeptides with potent anti-HIV activity
|
EP3316685A4
(de)
|
2015-07-02 |
2019-03-13 |
Otsuka Pharmaceutical Co., Ltd. |
Lyophilisierte pharmazeutische zusammensetzungen
|
LU92821B1
(en)
|
2015-09-09 |
2017-03-20 |
Mologen Ag |
Combination comprising immunostimulatory oligonucleotides
|
GB2542425A
(en)
|
2015-09-21 |
2017-03-22 |
Mologen Ag |
Means for the treatment of HIV
|
WO2017218580A1
(en)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Synthetic methods for the preparation of nicotinamide riboside and related compounds
|
US10202412B2
(en)
|
2016-07-08 |
2019-02-12 |
Atea Pharmaceuticals, Inc. |
β-D-2′-deoxy-2′-substituted-4′-substituted-2-substituted-N6-substituted-6-aminopurinenucleotides for the treatment of paramyxovirus and orthomyxovirus infections
|
RU2624018C2
(ru)
*
|
2016-09-26 |
2017-06-30 |
Федеральное государственное бюджетное учреждение науки Институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова РАН (ИБХ РАН) |
Амид 5-(тетрагидрофуран-2-ил)-1,2,4-триазол-3-карбоновой кислоты, обладающий противовирусной активностью, и способ его получения
|
WO2019025863A2
(en)
|
2017-08-03 |
2019-02-07 |
Otsuka Pharmaceutical Co., Ltd. |
MEDICAMENT COMPOUND AND METHODS OF PURIFICATION
|
WO2020157694A1
(en)
*
|
2019-02-01 |
2020-08-06 |
Janssen Biopharma, Inc. |
Antiviral nucleosides and derivatives thereof
|
IL293592A
(en)
|
2019-12-06 |
2022-08-01 |
Vertex Pharma |
Transduced tetrahydrofurans as sodium channel modulators
|
EP4347031A1
(de)
|
2021-06-04 |
2024-04-10 |
Vertex Pharmaceuticals Incorporated |
N-(hydroxyalkyl(hetero)aryl)tetrahydrofurancarboxamide als modulatoren von natriumkanälen
|
WO2023288047A2
(en)
*
|
2021-07-15 |
2023-01-19 |
Alnylam Pharmaceuticals, Inc. |
Multiplexing targeting ligands through click chemistry at the anomeric site of sugars
|